PROS1 and familial pancreatic carcinoma: An early study investigating the haemostatic balance in pancreatic cancer found that the coagulation inhibitors antithrombin III, heparin cofactor II, protein C, free protein S, and thrombomodulin were significantly decreased during the progression of pancreatic cancer after diagnosis [141].